Sally Shin — Ragon Institute of MGH, MIT and Harvard

Area of research

Infectious Diseases · Radiology, Nuclear Medicine and Imaging

Research interest

Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Monoclonal and Polyclonal Antibodies Research, and Tuberculosis Research and Epidemiology.

Recent publications

Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis

Nature Microbiology 2024cited by 19position: middledoi

Selective transfer of maternal antibodies in preterm and fullterm children

Scientific Reports 2022cited by 35position: middledoi

Evolution of functional antibodies following acute Epstein-Barr virus infection

PLoS Pathogens 2022cited by 22position: middledoi

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Nature 2021cited by 351position: middledoi

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

Nature 2021cited by 349position: middledoi

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung

Nature Communications 2021cited by 97position: middledoi

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Immunity 2021cited by 91position: middledoi

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

Science Translational Medicine 2021cited by 73position: middledoi

Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Cell 2020cited by 775position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Infectious Diseases · Radiology, Nuclear Medicine and Imaging →